Claes Held

2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee Developed by the task force on mental health and cardiovascular disease of the European Society of Cardiology (ESC) Endorsed by the European Federation of Psychologists' Associations AISBL (EFPA), the European Psychiatric Association (EPA), and the International Society of Behavioral Medicine (ISBM)

Bueno, Hector; Deaton, Christi; Farrero, Marta; Forsyth, Faye et al.

Part of European Heart Journal, 2025

• DOI for 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee Developed by the task force on mental health and cardiovascular disease of the European Society of Cardiology (ESC) Endorsed by the European Federation of Psychologists' Associations AISBL (EFPA), the European Psychiatric Association (EPA), and the International Society of Behavioral Medicine (ISBM)

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Arslani, Ketina; Engstrom, Thomas; Maeng, Michael; Kjoller-Hansen, Lars et al.

Part of JACC Cardiovascular Imaging, p. 696-706, 2025

• DOI for Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Muller, Matthew A.; Liu, Richard; Shah, Farheen; Hu, Jiyuan et al.

Part of Circulation, 2025

• DOI for Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Thrane, Pernille G.; Maeng, Michael; Maehara, Akiko; Bøtker, Hans Erik et al.

Part of Circulation, p. 1767-1779, 2025

• DOI for Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

Hag, Emma; Back, Maria; Henriksson, Peter; Wallert, John et al.

Part of European Journal of Cardiovascular Nursing, p. 253-263, 2025

• DOI for Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study
• Download full text (pdf) of Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee Developed by the task force on mental health and cardiovascular disease of the European Society of Cardiology (ESC) Endorsed by the European Federation of Psychologists' Associations AISBL (EFPA), the European Psychiatric Association (EPA), and the International Society of Behavioral Medicine (ISBM)

Bueno, Hector; Deaton, Christi; Farrero, Marta; Forsyth, Faye et al.

Part of European Heart Journal, 2025

• DOI for 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee Developed by the task force on mental health and cardiovascular disease of the European Society of Cardiology (ESC) Endorsed by the European Federation of Psychologists' Associations AISBL (EFPA), the European Psychiatric Association (EPA), and the International Society of Behavioral Medicine (ISBM)

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Arslani, Ketina; Engstrom, Thomas; Maeng, Michael; Kjoller-Hansen, Lars et al.

Part of JACC Cardiovascular Imaging, p. 696-706, 2025

• DOI for Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Muller, Matthew A.; Liu, Richard; Shah, Farheen; Hu, Jiyuan et al.

Part of Circulation, 2025

• DOI for Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Thrane, Pernille G.; Maeng, Michael; Maehara, Akiko; Bøtker, Hans Erik et al.

Part of Circulation, p. 1767-1779, 2025

• DOI for Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

Hag, Emma; Back, Maria; Henriksson, Peter; Wallert, John et al.

Part of European Journal of Cardiovascular Nursing, p. 253-263, 2025

• DOI for Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study
• Download full text (pdf) of Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

A randomized controlled trial of beta-blockers effects on cardiac anxiety

Leissner, Philip; Mars, Katarina; Humphries, Sophia; Jernberg, Tomas et al.

Part of General Hospital Psychiatry, p. 26-32, 2025

• DOI for A randomized controlled trial of beta-blockers effects on cardiac anxiety
• Download full text (pdf) of A randomized controlled trial of beta-blockers effects on cardiac anxiety

Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

Kjøller-Hansen, Lars; Maehara, Akiko; Kelbæk, Henning; Matsumura, Mitsuaki et al.

Part of Circulation. Cardiovascular Interventions, 2024

• DOI for Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Wassberg, Charlotte; Batra, Gorav; Hadziosmanovic, Nermin; Hagström, Emil et al.

Part of European Journal of Preventive Cardiology, p. 456-465, 2024

• DOI for Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy
• Download full text (pdf) of Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety

Leissner, Philip; Held, Claes; Humphries, Sophia; Rondung, Elisabet et al.

Part of European Journal of Cardiovascular Nursing, p. 720-727, 2024

• DOI for Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety
• Download full text (pdf) of Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

Leissner, Philip; Mars, Katarina; Humphries, Sophia; Karlström, Patric et al.

Part of European Heart Journal, p. 789-797, 2024

• DOI for Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
• Download full text (pdf) of Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Spitzer, Ernest; de la Torre Hernandez, Jose M.; Gudmundsdottir, Ingibjörg Jona; McFadden, Eugene et al.

Part of REC: Interventional Cardiology, p. 213-223, 2024

• DOI for Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
• Download full text (pdf) of Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Lund, Lars H; James, Stefan; DeVore, Adam D; Anstrom, Kevin J et al.

Part of European Journal of Heart Failure, p. 2453-2463, 2024

• DOI for The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design
• Download full text (pdf) of The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

Erlinge, David; Andersson, Jonas; Fröbert, Ole; Törnerud, Mattias et al.

Part of The Lancet, p. 1750-1759, 2024

• DOI for Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent

Erlinge, David; Andersson, Jonas; Froebert, Ole; Toernerud, Mattias et al.

Part of American Heart Journal, p. 1-10, 2024

• DOI for Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
• Download full text (pdf) of Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent

Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Fritz Hansson, Astrid; Modica, Angelo; Renlund, Henrik; Christersson, Christina et al.

Part of Open heart, 2024

• DOI for Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
• Download full text (pdf) of Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis

Bonaca, Marc P.; Bhatt, Deepak L.; Simon, Tabassome; Fox, Kim Michael et al.

Part of Journal of the American College of Cardiology, p. 1627-1636, 2024

• DOI for Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis

Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years

Omerovic, Elmir; James, Stefan; Råmundal, Truls; Fröbert, Ole et al.

Part of Cardiovascular Revascularization Medicine, p. 43-50, 2024

• DOI for Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years

Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation

Skogseid, Ebba-Louise; Batra, Gorav; Westerbergh, Johan; Held, Claes et al.

Part of Open heart, 2024

• DOI for Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation
• Download full text (pdf) of Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Reynolds, Harmony R.; Cyr, Derek D.; Bairey Merz, C. Noel; Shaw, Leslee J. et al.

Part of Journal of the American Heart Association, 2024

• DOI for Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial
• Download full text (pdf) of Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials

Hamo, Carine E.; Liu, Richard; Wu, Wenbo; Anthopolos, Rebecca et al.

Part of American Journal of Cardiology, p. 118-124, 2024

• DOI for Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI

Mars, Katarina; Humphries, Sophia; Leissner, Philip; Jonsson, Martin et al.

Part of European Heart Journal - Cardiovascular Pharmacotherapy, p. 708-718, 2024

• DOI for Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI
• Download full text (pdf) of Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction

Böhm, Felix; Mogensen, Brynjölfur; Engstrøm, Thomas; Stankovic, Goran et al.

Part of New England Journal of Medicine, p. 1481-1492, 2024

• DOI for FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Yndigegn, T.; Lindahl, Bertil; Mars, K.; Alfredsson, J. et al.

Part of New England Journal of Medicine, p. 1372-1381, 2024

• DOI for Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index

Fritz Hansson, Astrid; Jensevik Eriksson, Karin; Christersson, Christina; Held, Claes et al.

Part of Journal of the American Heart Association, 2023

• DOI for Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index
• Download full text (pdf) of Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index

Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study

Humphries, Sophia; Mars, Katarina; Hofmann, Robin; Held, Claes et al.

Part of European Heart Journal Open, 2023

• DOI for Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study
• Download full text (pdf) of Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

Ishak, Divan; Aktaa, Suleman; Lindhagen, Lars; Alfredsson, Joakim et al.

Part of Heart, p. 1159-1165, 2023

• DOI for Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
• Download full text (pdf) of Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Gyldenkerne, Christine; Maeng, Michael; Kjøller-Hansen, Lars; Maehara, Akiko et al.

Part of Circulation, p. 469-481, 2023

• DOI for Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Sundström, Johan; Lind, Lars; Nowrouzi, Shamim; Hagström, Emil et al.

Part of Journal of the American Medical Association (JAMA), p. 1160-1160, 2023

• DOI for Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Davidsson, Pia; Eketjall, Susanna; Eriksson, Niclas; Walentinsson, Anna et al.

Part of Cardiovascular Research, p. 1596-1605, 2023

• DOI for Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease

Nguyen, Dan D.; Spertus, John A.; Alexander, Karen P.; Newman, Jonathan D. et al.

Part of Journal of the American College of Cardiology, p. 1697-1709, 2023

• DOI for Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease

Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Olszowka, Maciej; Hagström, Emil; Hadziosmanovic, Nermin; Ljunggren, Mirjam et al.

Part of International Journal of Cardiology, 2023

• DOI for Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome
• Download full text (pdf) of Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials

Newman, Jonathan D.; Anthopolos, Rebecca; Ruggles, Kelly V.; Cornwell, Macintosh et al.

Part of American Heart Journal, p. 61-73, 2023

• DOI for Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn, Agneta; Eriksson, Niclas; Assarsson, Erika; Lundberg, Martin et al.

Part of PLOS ONE, 2023

• DOI for Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
• Download full text (pdf) of Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population

Leissner, Philip; Held, Claes; Rondung, Elisabet; Olsson, Erik M.G.

Part of BMC Medical Research Methodology, 2022

• DOI for The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population
• Download full text (pdf) of The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population

Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study

Rondung, Elisabet; Humphries, Sophia; Olsson, Erik M. G.; Sundelin, Runa et al.

Part of Internet Interventions, 2022

• DOI for Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study
• Download full text (pdf) of Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study

Editorial commentary: Emotional distress in women after acute myocardial infarction – still a long way to walk

Held, Claes

Part of Trends in cardiovascular medicine, p. 348-349, 2022

• DOI for Editorial commentary: Emotional distress in women after acute myocardial infarction – still a long way to walk

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Held, Claes; Hadziosmanovic, Nermin; Aylward, Philip E.; Hagström, Emil et al.

Part of Journal of the American Heart Association, 2022

• DOI for Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy
• Download full text (pdf) of Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

Mark, Daniel B.; Spertus, John A.; Bigelow, Robert; Anderson, Sophia et al.

Part of Circulation, p. 1294-1307, 2022

• DOI for Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018

Sharma, Abhinav; Mahaffey, Kenneth W; Gibson, C Michael; Hicks, Karen A et al.

Part of American Heart Journal, p. 93-104, 2022

• DOI for Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018
• Download full text (pdf) of Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

Yndigegn, Troels; Lindahl, Bertil; Alfredsson, Joakim; Benatar, Jocelyne et al.

Part of European Heart Journal - Cardiovascular Pharmacotherapy, p. 192-197, 2022

• DOI for Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
• Download full text (pdf) of Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Heerspink, Hiddo J L; Cherney, David; Postmus, Douwe; Stefánsson, Bergur V et al.

Part of Kidney International, p. 174-184, 2022

• DOI for A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
• Download full text (pdf) of A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Al-Khatib, Sana M.; Wojdyla, Daniel M.; Granger, Christopher B.; Wallentin, Lars et al.

Part of Circulation, p. 958-960, 2022

• DOI for Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes

Batra, Gorav; Lindbäck, Johan; Becker, Richard C.; Harrington, Robert A. et al.

Part of Journal of the American College of Cardiology, p. 1735-1747, 2022

• DOI for Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes

Independence of clinical events committees: A consensus statement from clinical research organizations

Spitzer, Ernest; Fanaroff, Alexander C.; Gibson, C. Michael; Seltzer, Jonathan et al.

Part of American Heart Journal, p. 120-129, 2022

• DOI for Independence of clinical events committees: A consensus statement from clinical research organizations

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Sjölin, Karl; Aulin, Julia; Wallentin, Lars; Eriksson, Niclas et al.

Part of Journal of the American Heart Association, 2022

• DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
• Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study

Christersson, Christina; Held, Claes; Modica, Angelo; Westerbergh, Johan et al.

Part of PLOS ONE, 2022

• DOI for Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study
• Download full text (pdf) of Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study

The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial

Olsson, Erik; Norlund, Fredrika; Rondung, Elisabet; Humphries, Sophia et al.

Part of Trials, 2022

• DOI for The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial
• Download full text (pdf) of The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial

Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.

Liljeroos, Thea; Puthoopparambil, Soorej Jose; Wallert, John; Held, Claes et al.

Part of Disability and Rehabilitation, p. 3834-3842, 2022

• DOI for Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.
• Download full text (pdf) of Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna et al.

Part of Frontiers in Physiology, 2022

• DOI for Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
• Download full text (pdf) of Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease

Batra, Gorav; Modica, Angelo; Renlund, Henrik; Larsson, Anders et al.

Part of Open heart, 2022

• DOI for Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
• Download full text (pdf) of Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease

Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study

Humphries, Sophia; Wallert, John; Mars, Katarina; Held, Claes et al.

Part of European Heart Journal, p. 491-500, 2022

• DOI for Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study
• Download full text (pdf) of Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study

Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry

Mars, Katarina; Wallert, John; Held, Claes; Humphries, Sophia et al.

Part of European Heart Journal, p. 372-379, 2021

• DOI for Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry
• Download full text (pdf) of Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin, Lars; Eriksson, Niclas; Olszowka, Maciej; Grammer, Tanja et al.

Part of PLoS Medicine, 2021

• DOI for Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
• Download full text (pdf) of Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Bosch, Jackie; Lonn, Eva M.; Jung, Hyejung; Zhu, Jun et al.

Part of European Heart Journal, p. 2995-3007, 2021

• DOI for Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
• Download full text (pdf) of Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Risk markers of incident atrial fibrillation in patients with coronary heart disease

Tomasdottir, Maria; Held, Claes; Hadziosmanovic, Nermin; Westerbergh, Johan et al.

Part of American Heart Journal, p. 92-101, 2021

• DOI for Risk markers of incident atrial fibrillation in patients with coronary heart disease
• Download full text (pdf) of Risk markers of incident atrial fibrillation in patients with coronary heart disease

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

Erlinge, David; Maehara, Akiko; Ben-Yehuda, Ori; Bötker, Hans Erik et al.

Part of The Lancet, p. 985-995, 2021

• DOI for Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Olszowka, Maciej; Held, Claes; Hadziosmanovic, Nermin; Denchev, Stefan et al.

Part of Journal of Internal Medicine, p. 392-403, 2021

• DOI for Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome
• Download full text (pdf) of Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Reynolds, Harmony R.; Shaw, Leslee J.; Min, James K.; Page, Courtney B. et al.

Part of Circulation, p. 1024-1038, 2021

• DOI for Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial

Abtan, Jeremie; Bhatt, Deepak L; Held, Claes; Simon, Tabassome et al.

Part of Circulation. Cardiovascular Interventions, 2021

• DOI for Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.

Heerspink, Hiddo J L; Sjöström, C David; Jongs, Niels; Chertow, Glenn M et al.

Part of European Heart Journal, p. 1216-1227, 2021

• DOI for Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
• Download full text (pdf) of Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Batra, Gorav; Ghukasyan, Tatevik; Lindbäck, Johan; Held, Claes et al.

Part of JAMA cardiology, p. 1440-1445, 2021

• DOI for Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial

Böhm, Felix; Mogensen, Brynjölfur; Östlund, Ollie; Engstrom, Thomas et al.

Part of American Heart Journal, p. 92-100, 2021

• DOI for The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
• Download full text (pdf) of The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial

Natriuretic peptides and incident atrial fibrillation

Tomasdottir, Maria; Held, Claes; Wallentin, Lars; Hijazi, Ziad

Part of American Heart Journal, p. 1-1, 2021

• DOI for Natriuretic peptides and incident atrial fibrillation

Assessing the external validity of the VALIDATE-SWEDEHEART trial

Rylance, Rebecca T.; Wagner, Philippe; Omerovic, Elmir; Held, Claes et al.

Part of Clinical Trials, p. 427-435, 2021

• DOI for Assessing the external validity of the VALIDATE-SWEDEHEART trial
• Download full text (pdf) of Assessing the external validity of the VALIDATE-SWEDEHEART trial

Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial

Bosch, Jackie; Lonn, Eva M.; Dagenais, Gilles R.; Gao, Peggy et al.

Part of Stroke, p. 2494-2501, 2021

• DOI for Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial

Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up

Humphries, Sophia; Wallert, John; Norlund, Fredrika; Wallin, Emma et al.

Part of Journal of Medical Internet Research, 2021

• DOI for Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up
• Download full text (pdf) of Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Schunk, Stefan J.; Kleber, Marcus E.; März, Winfried; Pang, Shichao et al.

Part of European Heart Journal, p. 1742-1756, 2021

• DOI for Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction

Ekerstad, Niklas; Javadzadeh, Dariush; Alexander, Karen P; Bergström, Olle et al.

Part of European Heart Journal, p. 89-98, 2021

• DOI for Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction
• Download full text (pdf) of Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction

Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease

McMurray, John J. V.; Wheeler, David C.; Stefánsson, Bergur V.; Jongs, Niels et al.

Part of Circulation, p. 438-448, 2021

• DOI for Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

Dalgaard, Frederik; Mulder, Hillary; Wojdyla, Daniel M.; Lopes, Renato D. et al.

Part of Circulation, p. 10-20, 2020

• DOI for Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

Initial Invasive or Conservative Strategy for Stable Coronary Disease

Maron, David J.; Hochman, Judith S.; Reynolds, Harmony R.; Bangalore, Sripal et al.

Part of New England Journal of Medicine, p. 1395-1407, 2020

• DOI for Initial Invasive or Conservative Strategy for Stable Coronary Disease

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

Reynolds, Harmony R.; Shaw, Leslee J.; Min, James K.; Spertus, John A. et al.

Part of JAMA cardiology, p. 773-786, 2020

• DOI for Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Garcia, David A; Fisher, Deborah A; Mulder, Hillary; Wruck, Lisa et al.

Part of American Heart Journal, p. 1-8, 2020

• DOI for Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Ögmundsdottir Michelsen, Halldora; Sjölin, Ingela; Schlyter, Mona; Hagström, Emil et al.

Part of European Journal of Preventive Cardiology, p. 18-27, 2020

• DOI for Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Mahmoodi, Bakhtawar K.; Tragante, Vinicius; Kleber, Marcus E.; Holmes, Michael V. et al.

Part of Circulation, p. 546-555, 2020

• DOI for Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Organization of intensive cardiac care units in Europe: Results of a multinational survey

Claeys, M. J.; Roubille, F.; Casella, G.; Zukermann, R. et al.

Part of European Heart Journal, p. 993-1001, 2020

• DOI for Organization of intensive cardiac care units in Europe: Results of a multinational survey

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

Heerspink, Hiddo J L; Stefansson, Bergur V; Chertow, Glenn M; Correa-Rotter, Ricardo et al.

Part of Nephrology, Dialysis and Transplantation, p. 274-282, 2020

• DOI for Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Part of JAMA Network Open, 2020

• DOI for Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

White, Harvey D.; Stewart, Ralph A. H.; Dolby, Anthony J.; Stebbins, Amanda et al.

Part of American Heart Journal, p. 97-107, 2020

• DOI for In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Hilvo, Mika; Wallentin, Lars; Ghukasyan, Tatevik; Held, Claes et al.

Part of Journal of the American Heart Association, 2020

• DOI for Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
• Download full text (pdf) of Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Stone, Gregg W.; Maehara, Akiko; Ali, Ziad A.; Held, Claes et al.

Part of Journal of the American College of Cardiology, p. 2289-2301, 2020

• DOI for Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Attending Heart School and long-term outcome after myocardial infarction: A decennial SWEDEHEART registry study

Wallert, John; Olsson, Erik M. G.; Pingel, Ronnie; Norlund, Fredrika et al.

Part of European Journal of Preventive Cardiology, p. 145-154, 2020

• DOI for Attending Heart School and long-term outcome after myocardial infarction: A decennial SWEDEHEART registry study

Psycho-affective pathology in adults with congenital heart disease: Important progress is being made within a challenging field

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

Part of European Journal of Preventive Cardiology, p. 378-380, 2020

• DOI for Psycho-affective pathology in adults with congenital heart disease: Important progress is being made within a challenging field

Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach

Humphries, Sophia; Rondung, Elisabet; Norlund, Fredrika; Sundin, Örjan et al.

Part of Journal of Medical Internet Research, 2020

• DOI for Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach
• Download full text (pdf) of Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach

Authorship: from credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Part of Basic Research in Cardiology, 2019

• DOI for Authorship: from credit to accountability. Reflections from the Editors' Network.

Authorship: From Credit to Accountability Reflections From the Editors´ Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean Jacques; Aschermann, Michael et al.

Part of Anatolian journal of cardiology, p. 281-286, 2019

• DOI for Authorship: From Credit to Accountability Reflections From the Editors´ Network.

Authorship: From credit to accountability - Reflections from the Editors' network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Part of Archivos de cardiologia de Mexico, p. 105-111, 2019

• DOI for Authorship: From credit to accountability - Reflections from the Editors' network.

Authorship: From credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Part of Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, p. 519-525, 2019

• DOI for Authorship: From credit to accountability. Reflections from the Editors' Network.

Authorship: from credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Part of Clinical Research in Cardiology, p. 723-729, 2019

• DOI for Authorship: from credit to accountability. Reflections from the Editors' Network.

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

McMurray, John J V; DeMets, David L; Inzucchi, Silvio E; Køber, Lars et al.

Part of European Journal of Heart Failure, p. 665-675, 2019

• DOI for A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

Authorship: From credit to accountability - Reflections from the Editors' network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Part of Archivos de cardiologia de Mexico, p. 93-99, 2019

• DOI for Authorship: From credit to accountability - Reflections from the Editors' network.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Patel, Riyaz S.; Schmidt, Amand F.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Part of Circulation, 2019

• DOI for Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
• Download full text (pdf) of Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Patel, Riyaz S.; Tragante, Vinicius; Schmidt, Amand F.; McCubrey, Raymond O. et al.

Part of Circulation, 2019

• DOI for Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
• Download full text (pdf) of Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

Fanaroff, Alexander C.; Clare, Robert; Pieper, Karen S.; Mahaffey, Kenneth W. et al.

Part of Circulation, p. 863-873, 2019

• DOI for Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Bhatt, Deepak L.; Fox, Kim; Harrington, Robert A.; Leiter, Lawrence A. et al.

Part of Clinical Cardiology, p. 498-505, 2019

• DOI for Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
• Download full text (pdf) of Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Krug-Gourley, Sue; Waterworth, Dawn et al.

Part of Journal of the American Heart Association, 2019

• DOI for Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease
• Download full text (pdf) of Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Bhatt, Deepak L.; Steg, Philippe Gabriel; Mehta, Shamir R.; Leiter, Lawrence A. et al.

Part of The Lancet, p. 1169-1180, 2019

• DOI for Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

When do we need clinical endpoint adjudication in clinical trials?

Held, Claes

Part of Upsala Journal of Medical Sciences, p. 42-45, 2019

• DOI for When do we need clinical endpoint adjudication in clinical trials?
• Download full text (pdf) of When do we need clinical endpoint adjudication in clinical trials?

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

Held, Claes; White, Harvey D.; Stewart, Ralph A. H.; Davies, Richard et al.

Part of American Heart Journal, p. 65-73, 2019

• DOI for Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial
• Download full text (pdf) of Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

McMurray, J. J. V.; Solomon, S. D.; Inzucchi, S. E.; Kober, L. et al.

Part of New England Journal of Medicine, p. 1995-2008, 2019

• DOI for Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients

Khunti, Kamlesh; Jung, Hyejung; Dans, Antonio L.; Held, Claes et al.

Part of Canadian Journal of Cardiology, p. 644-652, 2019

• DOI for Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients

Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Wallert, John; Mitchell, Adam; Held, Claes; Hagström, Emil et al.

Part of International Journal of Cardiology, p. 19-24, 2019

• DOI for Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study
• Download full text (pdf) of Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Steg, P. Gabriel; Bhatt, Deepak L.; Simon, Tabassome; Fox, Kim et al.

Part of New England Journal of Medicine, p. 1309-1320, 2019

• DOI for Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Should we consider early de-escalation of maintenance dose of antiplatelet therapy post-ACS?

Held, Claes

Part of European Heart Journal - Cardiovascular Pharmacotherapy, p. 149-150, 2019

• DOI for Should we consider early de-escalation of maintenance dose of antiplatelet therapy post-ACS?

Persistent emotional distress after a first-time myocardial infarction and its assocation to late cardiovascular and non-cardiovascular mortality

Lissåker, Claudia; Norlund, Fredrika; Wallert, John; Held, Claes et al.

Part of European Journal of Preventive Cardiology, p. 1510-1518, 2019

• DOI for Persistent emotional distress after a first-time myocardial infarction and its assocation to late cardiovascular and non-cardiovascular mortality

Effects of blood pressure and lipid lowering on cognition Results from the HOPE-3 study

Bosch, Jackie; O'Donnell, Martin; Swaminathan, Balakumar; Lonn, Eva Marie et al.

Part of Neurology, 2019

• DOI for Effects of blood pressure and lipid lowering on cognition Results from the HOPE-3 study

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Hochman, Judith S.; Held, Claes; Jeffries, Neal

Part of JAMA cardiology, p. 273-286, 2019

• DOI for Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Norlund, Fredrika; Wallin, Emma; Olsson, Erik; Wallert, John et al.

Part of Journal of Medical Internet Research, 2018

• DOI for Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial
• Download full text (pdf) of Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Ungar, Leo; Clare, Robert M.; Rodriguez, Fatima; Kolls, Bradley J. et al.

Part of Journal of the American Heart Association, 2018

• DOI for Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial
• Download full text (pdf) of Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial

Dagenais, Gilles R.; Jung, Hyejung; Lonn, Eva; Bogaty, Peter M. et al.

Part of Journal of the American Heart Association, 2018

• DOI for Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial
• Download full text (pdf) of Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

Pol, Tymon; Held, Claes; Westerbergh, Johan; Lindbäck, Johan et al.

Part of Journal of the American Heart Association, 2018

• DOI for Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Sharma, Abhinav; Hijazi, Ziad; Andersson, Ulrika; Al-Khatib, Sana M. et al.

Part of Circulation, p. 1666-1676, 2018

• DOI for Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial

Wallert, John; Gustafson, Emelie; Held, Claes; Madison, Guy et al.

Part of Journal of Medical Internet Research, 2018

• DOI for Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial
• Download full text (pdf) of Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial

Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry

Norlund, Fredrika; Lissåker, Claudia; Wallert, John; Held, Claes et al.

Part of European Journal of Preventive Cardiology, p. 910-920, 2018

• DOI for Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry
• Download full text (pdf) of Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

Vinereanu, Dragos; Wang, Alice; Mulder, Hillary; Lopes, Renato D. et al.

Part of Heart, p. 1292-1299, 2018

• DOI for Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

Scirica, Benjamin M.; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W. et al.

Part of American Heart Journal, p. 54-60, 2018

• DOI for Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Tricoci, Pierluigi; Neely, Megan; Whitley, Michael J.; Edelstein, Leonard C. et al.

Part of Blood Cells, Molecules & Diseases, p. 37-43, 2018

• DOI for Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

Tricoci, Pierluigi; Newby, L. Kristin; Clare, Robert M.; Leonardi, Sergio et al.

Part of JACC, p. 856-864, 2018

• DOI for Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study

Wallin, Emma; Norlund, Fredrika; Olsson, Erik; Burell, Gunilla et al.

Part of Journal of Medical Internet Research, 2018

• DOI for Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study
• Download full text (pdf) of Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study

Response to Letter: 'Sorrow and cardiovascular events'

Hagström, Emil; Held, Claes

Part of Journal of Internal Medicine, p. 415-415, 2018

• DOI for Response to Letter: 'Sorrow and cardiovascular events'

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Szummer, Karolina; Wallentin, Lars C.; Lindhagen, Lars; Alfredsson, Joakim et al.

Part of European Heart Journal, p. 3766-3776, 2018

• DOI for Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

Lindholm, Daniel P; James, Stefan K; Gabrysch, Katja; Storey, Robert F et al.

Part of JAMA cardiology, p. 1160-1166, 2018

• DOI for Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Hagström, Emil; Norlund, Fredrika; Stebbins, Amanda; Armstrong, P W et al.

Part of Journal of Internal Medicine, p. 83-92, 2018

• DOI for Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Web-Based Cognitive Behavior Therapy for Depression and Anxiety among Patients with a recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Norlund, Fredrika; Wallin, Emma; Olsson, Erik; Wallert, John et al.

Part of Journal of the American College of Cardiology, p. 1884-1884, 2018

• DOI for Web-Based Cognitive Behavior Therapy for Depression and Anxiety among Patients with a recent Myocardial Infarction: The U-CARE Heart Randomized Trial

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Part of European Heart Journal, p. 477-485, 2018

• DOI for A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
• Download full text (pdf) of A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Guimarães, Patrícia O; Leonardi, Sergio; Huang, Zhen; Wallentin, Lars et al.

Part of American Heart Journal, p. 28-35, 2018

• DOI for Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial

Olsson, Erik; Norlund, Fredrika; Pingel, Ronnie; Burell, Gunilla et al.

Part of Upsala Journal of Medical Sciences, Supplement, p. 167-173, 2018

• DOI for The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial
• Download full text (pdf) of The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

Pagidipati, Neha J.; Hess, Connie N.; Clare, Robert M.; Akerblom, Axel et al.

Part of American Heart Journal, p. 53-61, 2017

• DOI for An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

Ducrocq, Gregory; Schulte, Phillip J.; Budaj, Andrzej; Cornel, Jan H. et al.

Part of American Heart Journal, p. 91-99, 2017

• DOI for Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Lindholm, Daniel; Lindbäck, Johan; Armstrong, Paul W.; Budaj, Andrzej et al.

Part of Journal of the American College of Cardiology, p. 813-826, 2017

• DOI for Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

Bahit, M. Cecilia; Lopes, Renato D.; Wojdyla, Daniel M.; Held, Claes et al.

Part of Heart, p. 623-628, 2017

• DOI for Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
• Download full text (pdf) of Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Hagström, Emil; Held, Claes; Stewart, Ralph A H; Aylward, Philip E et al.

Part of Clinical Chemistry, p. 325-333, 2017

• DOI for Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Valgimigli, Marco; Costa, Francesco; Lokhnygina, Yuliya; Clare, Robert M. et al.

Part of European Heart Journal, p. 804-810, 2017

• DOI for Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data

Wallert, John; Tomasoni, Mattia; Madison, Guy; Held, Claes

Part of BMC Medical Informatics and Decision Making, p. 1-11, 2017

• DOI for Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data
• Download full text (pdf) of Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data

Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

Part of American Heart Journal, p. 12-20, 2017

• DOI for Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study
• Download full text (pdf) of Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Harskamp, Ralf E.; Clare, Robert M.; Ambrosio, Giuseppe; Held, Claes et al.

Part of European Heart Journal, p. 155-163, 2017

• DOI for Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Part of International Journal of Cardiology, p. 271-276, 2017

• DOI for Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Stewart, Ralph A H; Hagström, Emil; Held, Claes; Wang, Tom Kai Ming et al.

Part of Journal of the American Heart Association, 2017

• DOI for Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
• Download full text (pdf) of Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer, Karolina; Wallentin, Lars; Lindhagen, Lars; Alfredsson, Joakim et al.

Part of European Heart Journal, p. 3056-3065, 2017

• DOI for Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014
• Download full text (pdf) of Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Held, Claes; White, Harvey D.; Stewart, Ralph A. H.; Budaj, Andrzej et al.

Part of Journal of the American Heart Association, 2017

• DOI for Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Vidal-Petiot, Emmanuelle; Stebbins, Amanda; Chiswell, Karen; Ardissino, Diego et al.

Part of European Heart Journal, p. 2813-2822, 2017

• DOI for Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Erlinge, D.; Omerovic, E.; Fröbert, O.; Linder, R. et al.

Part of New England Journal of Medicine, p. 1132-1142, 2017

• DOI for Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Hadziosmanovic, Nermin; Armstrong, Paul W. et al.

Part of Journal of the American College of Cardiology, p. 1689-1700, 2017

• DOI for Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Guimaraes, Patricia Oliveira; Granger, Christopher B.; Stebbins, Amanda; Chiswell, Karen et al.

Part of Journal of the American Heart Association, 2017

• DOI for Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
• Download full text (pdf) of Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial

Guimaraes, P. Oliveira; Granger, C. B.; Chiswell, K.; Stebbins, A. et al.

Part of European Heart Journal, p. 188-188, 2017

• DOI for Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

Hess, Connie N.; Clare, Robert M.; Neely, Megan L.; Tricoci, Pierluigi et al.

Part of American Heart Journal, p. 194-203, 2017

• DOI for Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease

Carrero, Juan-Jesus; Varenhorst, Christoph; Jensevik, Karin; Szummer, Karolina et al.

Part of Kidney International, p. 216-226, 2017

• DOI for Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease

Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013

Lissåker, Claudia T.; Wallert, John; Held, Claes; Olsson, Erik

Part of Journal of Psychosomatic Research, p. 30-37, 2017

• DOI for Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013
• Download full text (pdf) of Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013

Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study

Wallert, John; Lissåker, Claudia; Madison, Guy; Held, Claes et al.

Part of European Journal of Preventive Cardiology, p. 639-646, 2017

• DOI for Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study
• Download full text (pdf) of Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study

Psychological mediators related to clinical outcome in cognitive behavioural therapy for coronary heart disease: A sub-analysis from the SUPRIM trial

Norlund, Fredrika; Olsson, Erik MG; Pingel, Ronnie; Held, Claes et al.

Part of European Journal of Preventive Cardiology, p. 917-925, 2017

• DOI for Psychological mediators related to clinical outcome in cognitive behavioural therapy for coronary heart disease: A sub-analysis from the SUPRIM trial

Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study

Wallert, John; Madison, Guy; Held, Claes; Olsson, Erik

Part of International Journal of Cardiology, p. 13-17, 2017

• DOI for Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study
• Download full text (pdf) of Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study

Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study

Grönqvist, Helena; Olsson, Erik; Johansson, Birgitta; Held, Claes et al.

Part of Journal of Medical Internet Research, 2017

• DOI for Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study
• Download full text (pdf) of Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Zewinger, Stephen; Kleber, Marcus E.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Part of The Lancet Diabetes and Endocrinology, p. 534-543, 2017

• DOI for Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

Lopes, Renato D.; Guimaraes, Patricia O.; Kolls, Bradley J.; Wojdyla, Daniel M. et al.

Part of Blood, p. 2980-2987, 2017

• DOI for Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

Clinical Outcomes Associated With The Duration Of Dual Antiplatelet Therapy With Clopidogrel And Aspirin In Chronic Kidney Disease Patients With Acute Coronary Syndrome

Carrero, Juan J.; Varenhorst, Christoph; Jensevik, Karin; Szummer, Karolina et al.

Part of Nephrology, Dialysis and Transplantation, p. 1441-1441, 2016

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

Hess, Paul L.; Wojdyla, Daniel M.; Al-Khatib, Sana M.; Lokhnygina, Yuliya et al.

Part of JAMA cardiology, p. 73-79, 2016

• DOI for Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Yusuf, Salim; Bosch, Jackie; Dagenais, Gilles; Zhu, Jun et al.

Part of New England Journal of Medicine, p. 2021-31, 2016

• DOI for Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

Vranckx, Pascal; White, Harvey D.; Huang, Zhen; Mahaffey, Kenneth W. et al.

Part of Journal of the American College of Cardiology, p. 2135-2144, 2016

• DOI for Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

Prediction Of Major Bleeding In Revascularized Patients With Acute Coronary Syndromes: Development Of A Novel Biomarker-Based Clinical Prediction Model

Lindholm, Daniel; Lindbäck, Johan; James, Stefan; Becker, Richard et al.

Part of Journal of the American College of Cardiology, p. 493-493, 2016

Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Part of European Journal of Preventive Cardiology, p. 839-846, 2016

• DOI for Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Stewart, Ralph A. H.; Wallentin, Lars; Benatar, Jocelyne; Danchin, Nicolas et al.

Part of European Heart Journal, p. 1993-2001, 2016

• DOI for Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
• Download full text (pdf) of Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis Results From the TRACER Angiographic Substudy

Popma, Christopher J.; Sheng, Shi; Korjian, Serge; Daaboul, Yazan et al.

Part of Circulation. Cardiovascular Interventions, 2016

• DOI for Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis Results From the TRACER Angiographic Substudy

All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Batra, Gorav; Svennblad, Bodil; Held, Claes; Jernberg, Tomas et al.

Part of Heart, p. 926-933, 2016

• DOI for All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

Déry, Jean-Pierre; Mahaffey, Kenneth W; Tricoci, Pierluigi; White, Harvey D et al.

Part of Catheterization and cardiovascular interventions, p. 163-173, 2016

• DOI for Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial

Durheim, Michael T.; Cyr, Derek D.; Lopes, Renato D.; Thomas, Laine E. et al.

Part of International Journal of Cardiology, p. 589-594, 2016

• DOI for Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial

Pooled analysis of adverse event collection from 4 acute coronary syndrome trials

Zimerman, Andre; Lopes, Renato D.; Stebbins, Amanda L.; Guimaraes, Patricia O. et al.

Part of American Heart Journal, p. 60-67, 2016

• DOI for Pooled analysis of adverse event collection from 4 acute coronary syndrome trials

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

De Caterina, Raffaele; Andersson, Ulrika; Alexander, John H.; Al-Khatib, Sana M. et al.

Part of American Heart Journal, p. 175-183, 2016

• DOI for History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
• Download full text (pdf) of History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

Diabetes Mellitus And Cardiovascular Risk In Patients With Chronic Coronary Heart Disease

Sinnaeve, Peter R.; Hagström, Emil; Armstrong, Paul; Budaj, Andrzej et al.

Part of Journal of the American College of Cardiology, p. 2162-2162, 2016

The Relationship Between Tooth Loss, Cardiovascular Biomarkers And Outcomes In Patients With Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Part of Journal of the American College of Cardiology, p. 1969-1969, 2016

Self-Reported General Health And Outcomes In Patients With Stable Coronary Artery Disease: Experiences From The Global Stability Trial

Stewart, Ralph Alan Huston; Hagström, Emil; Held, Claes; Armstrong, Paul et al.

Part of Journal of the American College of Cardiology, p. 2113-2113, 2016

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Armaganijan, Luciana V.; Alexander, Karen P.; Huang, Zhen; Tricoci, Pierluigi et al.

Part of American Heart Journal, p. 176-184, 2016

• DOI for Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Åkerblom, Axel; Clare, Robert M.; Lokhnygina, Yuliya; Wallentin, Lars et al.

Part of American Heart Journal, p. 1-8, 2016

• DOI for Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Wallentin, Lars; Held, Claes; Armstrong, Paul W.; Cannon, Christopher P. et al.

Part of Journal of the American Heart Association, 2016

• DOI for Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Bui, An H.; Cannon, Christopher P.; Steg, Philippe Gabriel; Storey, Robert F. et al.

Part of Circulation, 2016

• DOI for Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART.

Damman, Peter; Jernberg, Tomas; Lindahl, Bertil; de Winter, Robbert J et al.

Part of EuroIntervention, p. 1108-1116, 2016

Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.

Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro et al.

Part of Canadian Journal of Cardiology, p. 311-318, 2016

• DOI for Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Yusuf, Salim; Lonn, Eva; Pais, Prem; Bosch, Jackie et al.

Part of New England Journal of Medicine, p. 2032-2043, 2016

• DOI for Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Lonn, Eva M.; Bosch, Jackie; Lopez-Jaramillo, Patricio; Zhu, Jun et al.

Part of New England Journal of Medicine, p. 2009-2020, 2016

• DOI for Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Hijazi, Ziad; Lindbäck, Johan; Alexander, John H.; Hanna, Michael et al.

Part of European Heart Journal, p. 1582-1590, 2016

• DOI for The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Part of The Lancet, p. 2302-2311, 2016

• DOI for The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

Cornel, Jan H.; Tricoci, Pierluigi; Lokhnygina, Yuliya; Moliterno, David J. et al.

Part of American Journal of Cardiology, p. 1325-1332, 2015

• DOI for Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

Growth Differentiation Factor-15 (GDF-15) For Prognostication Of Outcomes In Stable Coronary Artery Disease: Experiences From The Stability Trial

Wallentin, Lars; Held, Claes; Stewart, Ralph; Budaj, Andrzej et al.

Part of Journal of the American College of Cardiology, 2015

Tooth Loss Is Independently Associated With Adverse Outcome But Not Myocardial Infarction In Patients With Chronic Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Part of Journal of the American College of Cardiology, 2015

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

van Diepen, Sean; Tricoci, Pierluigi; Podder, Mohua; Westerhout, Cynthia M et al.

Part of Journal of the American Heart Association, 2015

• DOI for Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery
• Download full text (pdf) of Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation: insights from the ARISTOTLE trial

Bahit, M. C.; Lopes, R. D.; Wojdyla, D. M.; Held, Claes et al.

Part of European Heart Journal, p. 338-339, 2015

External validation of the biomarker-based ABC-stroke risk score for atrial fibrillation

Hijazi, Ziad; Lindbäck, Johan; Östlund, Olof Petter; Siegbahn, Agneta et al.

Part of European Heart Journal, p. 710-711, 2015

Balancing the risk of ischaemic and bleeding events in ACS

Ducrocq, G.; Schulte, P. J.; Budaj, A.; Cornel, J. H. et al.

Part of European Heart Journal, p. 860-861, 2015

Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy

Wallentin, Lars C.; Lindbäck, Johan; Held, Claes; Granger, C. B. et al.

Part of European Heart Journal, p. 1041-1042, 2015

Effect of ivabradine on heart rate variability in patients with stable coronary artery disease

Stewart, R. A. H.; Armstrong, P. W.; Chiswell, K.; Hagström, Emil et al.

Part of European Heart Journal, p. 1088-1088, 2015

Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial

Held, Claes; White, H. D.; Stewart, R. A. H.; Davies, R. et al.

Part of European Heart Journal, p. 1104-1104, 2015

Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study

Andersen, Kasper; Rasmussen, Finn; Held, Claes; Neovius, Martin et al.

Part of BMJ-BRITISH MEDICAL JOURNAL, 2015

• DOI for Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study
• Download full text (pdf) of Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Kang, Hyun-Jae; Clare, Robert M.; Gao, Runlin; Held, Claes et al.

Part of American Heart Journal, p. 899-+, 2015

• DOI for Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
• Download full text (pdf) of Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan L et al.

Part of European Journal of Preventive Cardiology, p. 771-778, 2015

• DOI for Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

Ducrocq, Gregory; Schulte, P J; Becker, R C; Cannon, C P et al.

Part of EuroIntervention, p. 737-745, 2015

• DOI for Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Held, Claes; Hylek, Elaine M; Alexander, John H; Hanna, Michael et al.

Part of European Heart Journal, p. 1264-1272, 2015

• DOI for Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial

Norlund, Fredrika; Olsson, Erik M. G.; Burell, Gunilla; Wallin, Emma et al.

Part of Trials, 2015

• DOI for Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial
• Download full text (pdf) of Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

Bagai, Akshay; Huang, Zhen; Lokhnygina, Yuliya; Harrington, Robert A et al.

Part of Circulation. Cardiovascular Interventions, 2015

• DOI for Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

EACPR country of the month initiative: Sweden

Kiessling, Anna; Hambraeus, Kristina; Held, Claes; Norhammar, Anna et al.

Part of European Heart Journal, p. 951-952, 2015

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

Varenhorst, Christoph; Alström, Ulrica; Braun, Oscar Ö; Storey, Robert F et al.

Part of Heart, p. 1762-1769, 2014

• DOI for Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial

Tricoci, Pierluigi; Lokhnygina, Yuliya; Huang, Zhen; Van de Werf, Frans et al.

Part of American Heart Journal, p. 869-8770, 2014

• DOI for Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

Held, Claes; Tricoci, Pierluigi; Huang, Zhen; Van de Werf, Frans et al.

Part of European Heart Journal, p. 246-256, 2014

• DOI for Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

Jones, William Schuyler; Tricoci, Pierluigi; Huang, Zhen; Moliterno, David J et al.

Part of American Heart Journal, p. 588-596, 2014

• DOI for Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures

Garcia, David; Alexander, John H; Wallentin, Lars; Wojdyla, Daniel M et al.

Part of Blood, p. 3692-3698, 2014

• DOI for Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

Hylek, Elaine M.; Held, Claes; Alexander, John H.; Lopes, Renato D. et al.

Part of Journal of the American College of Cardiology, p. 2141-2147, 2014

• DOI for Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

Prognostic implications of major bleeding on mortality in ACS patients: An analysis of the PLATO trial

Ducrocq, G.; Schulte, P. J.; Cannon, C. P.; Becker, R. C. et al.

Part of European Heart Journal, p. 724-724, 2014

Chronic kidney disease is associated with worse outcomes in ACS patients: results from the TRACER trial

Mahaffey, K. W.; Pieper, K.; Vranckx, P.; Tricoci, P. et al.

Part of European Heart Journal, p. 687-687, 2014

ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients

Oskarsson, A.; Varenhorst, Christoph; Hagström, Emil; Wernroth, Mona-Lisa et al.

Part of European Heart Journal, p. 482-482, 2014

Dose–Response Relationship of Total and Leisure Time Physical Activity to Risk of Heart Failure: a prospective cohort study

Andersen, Kasper; Daniela, Mariosa; Adami, Hans-Olov; Held, Claes et al.

Part of Circulation Heart Failure, p. 701-708, 2014

• DOI for Dose–Response Relationship of Total and Leisure Time Physical Activity to Risk of Heart Failure: a prospective cohort study

Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Mahaffey, Kenneth W.; Held, Claes; Wojdyla, Daniel M.; James, Stefan K. et al.

Part of Journal of the American College of Cardiology, p. 1493-1499, 2014

• DOI for Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Halvorsen, Sigrun; Atar, Dan; Yang, Hongqiu; De Caterina, Raffaele et al.

Part of European Heart Journal, p. 1864-1872, 2014

• DOI for Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

Kotsia, Anna; Brilakis, Emmanouil S.; Held, Claes; Cannon, Christopher et al.

Part of American Heart Journal, p. 68-75, 2014

• DOI for Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

No misrepresentation of vital status follow-up in PLATO : Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014

Wallentin, Lars; Becker, Richard C.; Cannon, Christopher P.; Held, Claes et al.

Part of International Journal of Cardiology, p. 300-302, 2014

• DOI for No misrepresentation of vital status follow-up in PLATO : Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014

Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome

Varenhorst, Christoph; Jensevik, Karin; Jernberg, Tomas; Sundstrom, Anders et al.

Part of European Heart Journal, p. 969-978, 2014

• DOI for Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome

SWEDEHEART Annual Report 2012

Hambraeus, Kristina; Held, Claes; Johansson, Per; Svennberg, Lars et al.

Part of Scandinavian Cardiovascular Journal, p. 1, 2014

• DOI for SWEDEHEART Annual Report 2012

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Storey, Robert F; James, Stefan K; Siegbahn, Agneta; Varenhorst, Christoph et al.

Part of Platelets, p. 517-525, 2014

• DOI for Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score

Hijazi, Ziad; Lindbäck, Johan; Siegbahn, Agneta; Alexander, J. H. et al.

Part of European Heart Journal, p. 357-357, 2014

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth et al.

Part of New England Journal of Medicine, p. 1702-1711, 2014

• DOI for Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013

Wallentin, Lars; Becker, Richard C.; Cannon, Christopher P.; Held, Claes et al.

Part of International Journal of Cardiology, 2014

• DOI for Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013

Response to Letter Regarding Article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation"

Wallentin, Lars; Lopes, Renato D.; Hanna, Michael; Thomas, Laine et al.

Part of Circulation, 2014

• DOI for Response to Letter Regarding Article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation"

Darapladib for preventing ischemic events in stable coronary heart disease

White, Harvey D; Held, Claes; Stewart, Ralph; Tarka, Elizabeth et al.

Part of New England Journal of Medicine, p. 1702-1711, 2014

• DOI for Darapladib for preventing ischemic events in stable coronary heart disease

Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)

Mahaffey, Kenneth W.; Huang, Zhen; Wallentin, Lars; Storey, Robert F. et al.

Part of American Journal of Cardiology, p. 936-944, 2014

• DOI for Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)

Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery

Whellan, David J.; Tricoci, Pierluigi; Chen, Edmond; Huang, Zhen et al.

Part of Journal of the American College of Cardiology, p. 1048-1057, 2014

• DOI for Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery

Physical activity in patients with stable coronary heart disease: an international perspective

Stewart, Ralph; Held, Claes; Brown, Rebekkah; Vedin, Ola et al.

Part of European Heart Journal, p. 3286-3293, 2013

• DOI for Physical activity in patients with stable coronary heart disease: an international perspective

Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan et al.

Part of Journal of the American College of Cardiology, 2013

• DOI for Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?

Johnston, Nina; Bornefalk-Hermansson, Anna; Schenck-Gustafsson, Karin; Held, Claes et al.

Part of European Heart Journal, p. 350-358, 2013

• DOI for Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Vedin, Ola; Hagström, Emil; Stewart, Ralph; Brown, Rebekkah et al.

Part of European Journal of Preventive Cardiology, p. 678-685, 2013

• DOI for Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Undertreatment of elderly patients > 80-years with acute coronary syndrome despite high risk and similar benefits from evidence-based treatment as at younger age: results from SVEDEHEART

Held, Claes; Johanson, Per; Edberg, Annika; Bergström, Olle et al.

Part of Journal of the American College of Cardiology, 2013

• DOI for Undertreatment of elderly patients > 80-years with acute coronary syndrome despite high risk and similar benefits from evidence-based treatment as at younger age: results from SVEDEHEART

The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART)

Harnek, Jan; Nilsson, Johan; Friberg, Orjan; James, Stefan et al.

Part of Scandinavian Cardiovascular Journal, p. 1-10, 2013

• DOI for The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART)

Risk prediction in stable angina pectoris

Kahan, Thomas; Forslund, Lennart; Held, Claes; Björkander, Inge et al.

Part of European Journal of Clinical Investigation, p. 141-151, 2013

• DOI for Risk prediction in stable angina pectoris

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

Leonardi, Sergio; Tricoci, Pierluigi; White, Harvey D; Armstrong, Paul W et al.

Part of European Heart Journal, p. 1723-1731, 2013

• DOI for Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

Wallentin, Lars; Lopes, Renato D; Hanna, Michael; Thomas, Laine et al.

Part of Circulation, p. 2166-2176, 2013

• DOI for Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

Andersen, Kasper; Farahmand, Bahman; Ahlbom, Anders; Held, Claes et al.

Part of European Heart Journal, p. 3624-3631, 2013

• DOI for Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

Brilakis, Emmanouil S.; Held, Claes; Meier, Bernhard; Cools, Frank et al.

Part of American Heart Journal, p. 474-480, 2013

• DOI for Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial

Varenhorst, Christoph; Alström, Ulrica; Braun, O. O.; Storey, R. F. et al.

Part of European Heart Journal, p. 827-827, 2013

• DOI for Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial

Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial

Held, Claes; Hylek, E. B.; Alexander, J. H.; Hanna, M. et al.

Part of European Heart Journal, p. 99-99, 2013

• DOI for Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial

Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE

Lopes, R. D.; Garcia, D. A.; Wojdyla, D.; Dorian, P. et al.

Part of European Heart Journal, p. 98-99, 2013

• DOI for Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE

Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER

Jones, Schuyler; Tricoci, Pierluigi; Huang, Zhen; Moliterno, David J. et al.

Part of Circulation, 2013

Trends in Reperfusion Strategy 1995-2011 in Sweden. Results From the SWEDEHEART Registry

Held, Claes; Johanson, Per; Edberg, Annika; Mattsson, Eva et al.

Part of Circulation, 2013

CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial

Tricoci, Pierluigi; Chen, Edmond; Neely, Megan L.; Warner, Amelia et al.

Part of Circulation, 2013

Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Insights From the TRACER Trial

Armaganijan, Luciana; Lopes, Renato; Huang, Zhen; Tricoci, Pierluigi et al.

Part of Circulation, 2013

Arterial Access Site and Outcomes in Patients Undergoing Percutaneous Coronary Intervention With and Without Vorapaxar

Dery, Jean-Pierre P.; Mahaffey, Kenneth; Tricoci, Pierluigi; White, Harvey et al.

Part of Circulation, 2013

Differential Prognostic Implications of Peak Troponin Level in Acute Coronary Syndrome Treated With and Without Revascularization

Bagai, Akshay; Huang, Zhen; Lokhnygina, Yuliya; Harrington, Robert A. et al.

Part of Circulation, 2013

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Tricoci, Pierluigi; Huang, Zhen; Held, Claes; Moliterno, David J et al.

Part of New England Journal of Medicine, p. 20-33, 2012

• DOI for Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Improving long-term outcomeafter myocardial infarction

James, Stefan; Held, Claes

Part of The Lancet, p. 1290-1291, 2012

• DOI for Improving long-term outcomeafter myocardial infarction

Predictors of low physical activity in patients with stable coronary heart disease in the global STABILITY study

Stewart, R. A. H.; Held, Claes; Brown, R.; Vedin, O. et al.

Part of European Heart Journal, p. 953-953, 2012

• DOI for Predictors of low physical activity in patients with stable coronary heart disease in the global STABILITY study

Female gender associated with less use of reperfusion in ST-elevation myocardial infarction: a study from the RIKS-HIA registry

Johnston, N.; Bornefalk-Hermansson, Anna; Held, Claes; Schenck-Gustafsson, K.

Part of European Heart Journal, p. 468-469, 2012

• DOI for Female gender associated with less use of reperfusion in ST-elevation myocardial infarction: a study from the RIKS-HIA registry

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

Varenhorst, Christoph; Alström, Ulrica; Scirica, Benjamin M.; Hogue, Charles W. et al.

Part of Journal of the American College of Cardiology, p. 1623-1630, 2012

• DOI for Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

Hjärt-ultraljud för kliniker

Held, Claes

Part of Läkartidningen, 2012

Improving long-term outcome after myocardial infarction

James, Stefan; Held, Claes

Part of The Lancet, p. 1290-1291, 2012

• DOI for Improving long-term outcome after myocardial infarction

Gender perspectives on adherence to treatment guidelines in patients with acute myocardial infarction in Sweden

Johnston, Nina; Bornefalk-Hermansson, Anna; Held, Claes; Schenck-Gustafsson, Karin

Part of Circulation, 2012

• DOI for Gender perspectives on adherence to treatment guidelines in patients with acute myocardial infarction in Sweden

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Brilakis, Emmanouil; Held, Claes; Meier, Bernhard; Cools, Frank et al.

Part of Journal of the American College of Cardiology, 2012

• DOI for Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Invasive Strategies And Outcomes For Non-ST-segment Elevation Acute Coronary Syndromes: A Twelve-year Experience From SWEDEHEART

Damman, Peter; Held, Claes; James, Stefan; Jeppsson, Anders et al.

Part of Journal of the American College of Cardiology, 2012

• DOI for Invasive Strategies And Outcomes For Non-ST-segment Elevation Acute Coronary Syndromes: A Twelve-year Experience From SWEDEHEART

In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils

Paulsson, J. M.; Moshfegh, A.; Dadfar, E.; Held, Claes et al.

Part of Clinical and Experimental Immunology, p. 105-112, 2012

• DOI for In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils

Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study

Held, Claes; Iqbal, Romaina; Lear, Scott A.; Rosengren, Annika et al.

Part of European Heart Journal, p. 452-466, 2012

• DOI for Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study

Total and leisure time physical activity and risk of heart failure: a prospective cohort study

Andersen, Kasper; Mariosa, D.; Adami, H. O.; Held, Claes et al.

Part of European Heart Journal, p. 1052-1052, 2012

• DOI for Total and leisure time physical activity and risk of heart failure: a prospective cohort study

Riks-HIA ska ta fram nytt index för områden med förbättringsutrymme

Jernberg, Tomas; Bergström, Olle; Held, Claes; Johanson, Per et al.

Part of Läkartidningen, p. 672-673, 2012

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

Becker, Richard C; Bassand, Jean Pierre; Budaj, Andrzej; Wojdyla, Daniel M et al.

Part of European Heart Journal, p. 2933-2944, 2011

• DOI for Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study

Edström Plüss, Cathrine; Billing, Ewa; Held, Claes; Henriksson, Peter et al.

Part of Clinical Rehabilitation, p. 79-87, 2011

• DOI for Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

Jernberg, Tomas; Johanson, Per; Held, Claes; Svennblad, Bodil et al.

Part of Journal of the American Medical Association (JAMA), p. 1677-1684, 2011

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Held, Claes; Åsenblad, Nils; Bassand, Jean Pierre; Becker, Richard C. et al.

Part of Journal of the American College of Cardiology, p. 672-684, 2011

• DOI for Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study

Bennermo, Marie; Nordin, Margareta; Lundman, Pia; Boqvist, Susanna et al.

Part of Journal of Interferon and Cytokine Research, p. 259-264, 2011

• DOI for Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study

Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Mahaffey, Kenneth W.; Wojdyla, Daniel M.; Carroll, Kevin; Becker, Richard C. et al.

Part of Circulation, p. 544-554, 2011

• DOI for Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Plasma parathyroid hormone and risk of congestive heart failure in the community

Hagström, Emil; Ingelsson, Erik; Sundström, Johan; Hellman, Per et al.

Part of European Journal of Heart Failure, p. 1186-1192, 2010

• DOI for Plasma parathyroid hormone and risk of congestive heart failure in the community

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

White, Harvey; Held, Claes; Stewart, Ralph; Watson, David et al.

Part of American Heart Journal, p. 655-66100, 2010

• DOI for Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Hagström, Emil; Hellman, Per; Larsson, Tobias E.; Ingelsson, Erik et al.

Part of Circulation, p. 2765-2771, 2009

• DOI for Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Wallentin, Lars; Becker, Richard C.; Budaj, Andrzej; Cannon, Christopher P. et al.

Part of New England Journal of Medicine, p. 1045-1057, 2009

• DOI for Ticagrelor versus clopidogrel in patients with acute coronary syndromes

In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1

Paulsson, J. M.; Held, Claes; Jacobson, S. H.; Lundahl, J.

Part of Scandinavian Journal of Immunology, p. 368-376, 2009

• DOI for In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale

Harrington, Robert A.; Van de Werf, Frans; Armstrong, Paul W.; Aylward, Phil et al.

Part of American Heart Journal, p. 327-334, 2009

• DOI for The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale

Evaluation of a web-based ECG-interpretation programme for undergraduate medical students

Nilsson, Mikael; Bolinder, Gunilla; Held, Claes; Johansson, Bo-Lennart et al.

Part of BMC Medical Education, p. 25, 2008

• DOI for Evaluation of a web-based ECG-interpretation programme for undergraduate medical students

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease: results of the renal Hope-2 study

Mann, Johannes F. E.; Sheridan, Patrick; McQueen, Matthew J.; Held, Claes et al.

Part of Nephrology, Dialysis and Transplantation, p. 645-653, 2008

• DOI for Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease: results of the renal Hope-2 study

Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

Held, Claes; Sumner, Glen; Sheridan, Patrick; McQueen, Mathew et al.

Part of Vascular Medicine, p. 245-253, 2008

• DOI for Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b

Paulsson, J. M.; Dadfar, E.; Held, Claes; Jacobson, S. H. et al.

Part of Clinical and Experimental Immunology, p. 196-204, 2008

• DOI for In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b

Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris

Bjorkander, Inge; Forslund, Lennart; Kahan, Thomas; Ericson, Mats et al.

Part of Cardiology, p. 126-133, 2008

• DOI for Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris

Effects of Expanded Cardiac Rehabilitation on Psychosocial Status in Coronary Artery Disease with Focus on Type D Characteristics

Karlsson, Monica Rydell; Edström-Plüss, Catrin; Held, Claes; Henriksson, Peter et al.

Part of Journal of behavioral medicine, p. 253-261, 2007

• DOI for Effects of Expanded Cardiac Rehabilitation on Psychosocial Status in Coronary Artery Disease with Focus on Type D Characteristics

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Held, C; Gerstein, H C; Yusuf, S; Zhao, F et al.

Part of Circulation, p. 1371-1375, 2007

• DOI for Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease

Paulsson, Josefin; Dadfar, Elham; Held, Claes; Jacobson, Stefan H et al.

Part of Atherosclerosis, p. 328-334, 2007

• DOI for Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease

A high-fat meal is accompanied by increased plasma interleukin-6 concentrations

Lundman, Pia; Boquist, Susanna; Samnegård, Ann; Bennermo, Marie et al.

Part of NMCD. Nutrition Metabolism and Cardiovascular Diseases, p. 195-202, 2007

• DOI for A high-fat meal is accompanied by increased plasma interleukin-6 concentrations

Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

Mörtsell, David; Malmqvist, K; Held, Claes; Kahan, T

Part of Journal of Internal Medicine, p. 472-479, 2007

• DOI for Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery

Held, Claes; Tornvall, Per; Stenestrand, Ulf

Part of European Heart Journal, p. 316-325, 2007

• DOI for Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery

Venous thromboembolism in association with features of the metabolic syndrome

Ray, J. G.; Lonn, E.; Yi, Q.; Rathe, A. et al.

Part of QJM Monthly Journal of the Association of Physicians, p. 679-684, 2007

• DOI for Venous thromboembolism in association with features of the metabolic syndrome

Regression of left ventricular hypertrophy in human hypertension with irbesartan

Malmqvist, Karin; Kahan, Thomas; Edner, Magnus; Held, Claes et al.

Part of Journal of Hypertension, p. 1167-1176, 2001

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Spitzer, Ernest; de la Torre Hernández, José M.; Gudmundsdóttir, Ingibjörg Jóna; McFadden, Eugene et al.

Part of REC: Interventional Cardiology, p. 213-223, 2024

• DOI for Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
• Download full text (pdf) of Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials A Guidance Document

Spitzer, Ernest; McFadden, Eugene; Vranckx, Pascal; Garcia-Garcia, Hector M. et al.

Part of JACC, p. 805-819, 2019

• DOI for Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials A Guidance Document

Lessons from platelet inhibition and patient outcomes

Held, Claes

Part of Current Opinion in Cardiology, p. 355-360, 2012

• DOI for Lessons from platelet inhibition and patient outcomes

Myocardial infarction and artificial time-­constraint: a theoretical framework and national registry study of yearly, monthly, and weekly incidence variation

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

p. 788, 2016

Does a clinical history of gout influence the relationship of serum uric acid levels and cardiovascular outcomes among patients with acute coronary syndromes?

Pagidipati, N.; Hess, C. N.; Clare, R. M.; Åkerblom, Axel et al.

p. 458-458, 2016

Myocardial Infarction and Google Searches on "Stress"

Olsson, Erik; Held, Claes; Madison, Guy; Wallert, John

2016

Emotional Distress is a Predictor of Poor Long-Term Statin Adherence at Two Years After a Myocardial Infarction

Lissåker, Claudia; Wallert, John; Held, Claes; Olsson, Erik

2016

Cognitive Ability, Lifestyle Risk Factors, and Two-Year Mortality in First Myocardial Infarction Men: A Swedish National Registry Study

Wallert, John; Madison, Guy; Held, Claes; Olsson, Erik

2016

Decreased prevalence of psychological distress after acute myocardial infarction from 2006 to 2013

Norlund, Fredrika; Pingel, Ronnie; Held, Claes; Olsson, Erik

2016

The Development and Feasablity of an Internet-Based Cognitive Behavioral Intervention to reduce Depression and/or Anxiety after a Myocardial Infarction - The U-CARE Heart study

Norlund, Fredrika; Olsson, Erik; Wallin, Emma; Burell, Gunilla et al.

2016

• DOI for The Development and Feasablity of an Internet-Based Cognitive Behavioral Intervention to reduce Depression and/or Anxiety after a Myocardial Infarction - The U-CARE Heart study

Living alone and depressive symptoms are associated with major cardiovascular events in patients with chronic coronary heart disease

Hagström, Emil; Norlund, Fredrika; Harrington, R. A.; Lopez-Sendon, J. et al.

p. 1144-1144, 2015

U-CARE Heart: A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients with a Previous Myocardial Infarction: A Clinical Trial Protocol

Grönqvist, Helena; Olsson, Erik; Norlund, Fredrika; Wallin, Emma et al.

2013

U-CARE – internet-based psychosocial care and psychological treatment in connection to somatic disease

Olsson, Erik; Alfonsson, Sven; Ander, Malin; Brantnell, Anders et al.

2013

U-CARE: a research program on psychosocial care via the internet

Olsson, Erik; Alfonsson, Sven; Ander, Malin; Burell, Gunilla et al.

2012

Derivation and validation of STOPSMOKE: An instrument built from Swedish population data for predicting smoking abstinence post myocardial infarction

Wallert, John; Pingel, Ronnie; Schön, Thomas B.; Olsson, Erik et al.

Exercise capacity and muscle strength and risk of vascular disease and arrhythmias: A cohort study of 1.26 million young men

Andersen, Kasper; Held, Claes; Neovius, Martin; Tynelius, Per et al.

Randomized controlled trial of internet-based cognitive behavioral therapy in myocardial infarction with non-obstructive coronary arteries or takotsubo syndrome

Leissner, Philip; Sundelin, Runa; Rondung, Elisabet; Humphries, Sophia et al.